The NCTN is composed of various stakeholders, including:
Research Institutions: Academic centers and hospitals that conduct clinical trials Healthcare Providers: Oncologists, nurses, and other medical professionals Patients: Individuals participating in clinical trials Industry Partners: Pharmaceutical and biotechnology companies Regulatory Agencies: Organizations such as the FDA that oversee the approval of new treatments
